Vigil Neuroscience, Inc. (VIGL)
NASDAQ: VIGL · Real-Time Price · USD
3.000
-0.050 (-1.64%)
Nov 21, 2024, 4:00 PM EST - Market closed
Vigil Neuroscience Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 44.9 | 51.99 | 186.61 | 91.42 | 24.15 |
Short-Term Investments | 66.37 | 65.95 | - | - | - |
Cash & Short-Term Investments | 111.27 | 117.94 | 186.61 | 91.42 | 24.15 |
Cash Growth | -16.74% | -36.80% | 104.12% | 278.54% | - |
Other Receivables | 0.4 | 1.49 | 0.02 | - | - |
Receivables | 0.4 | 1.49 | 0.02 | - | - |
Prepaid Expenses | 1.08 | 1.69 | 6.8 | 5.7 | 1.08 |
Other Current Assets | 0.95 | 0.8 | 4.38 | 0.36 | 0.07 |
Total Current Assets | 113.69 | 121.91 | 197.81 | 97.48 | 25.3 |
Property, Plant & Equipment | 16.56 | 17.94 | 1.4 | 1.27 | - |
Long-Term Deferred Charges | - | - | - | 2.76 | - |
Other Long-Term Assets | 1.03 | 1.01 | 1.19 | 0.93 | - |
Total Assets | 131.27 | 140.86 | 200.39 | 102.44 | 25.3 |
Accounts Payable | 0.86 | 1.95 | 1.94 | 3.98 | 1.11 |
Accrued Expenses | 8.51 | 8.49 | 7.39 | 4.37 | 0.87 |
Current Portion of Leases | 1 | 0.91 | 0.18 | 0.87 | - |
Other Current Liabilities | 0.17 | 0.32 | 1.8 | 0.66 | 0.02 |
Total Current Liabilities | 30.55 | 11.66 | 11.31 | 9.88 | 2 |
Long-Term Debt | - | - | - | - | 0.3 |
Long-Term Leases | 12.18 | 12.95 | - | 0.06 | - |
Other Long-Term Liabilities | - | - | - | - | 4.25 |
Total Liabilities | 42.72 | 24.61 | 11.31 | 9.95 | 6.55 |
Common Stock | 0 | 0 | 0 | - | - |
Additional Paid-In Capital | 371.64 | 339.03 | 329.21 | 2.39 | 0.26 |
Retained Earnings | -283.2 | -222.77 | -140.13 | -71.83 | -28.55 |
Comprehensive Income & Other | 0.11 | -0.01 | - | - | - |
Total Common Equity | 88.55 | 116.25 | 189.08 | -69.44 | -28.28 |
Shareholders' Equity | 88.55 | 116.25 | 189.08 | 92.5 | 18.75 |
Total Liabilities & Equity | 131.27 | 140.86 | 200.39 | 102.44 | 25.3 |
Total Debt | 13.18 | 13.85 | 0.18 | 0.94 | 0.3 |
Net Cash (Debt) | 98.09 | 104.09 | 186.43 | 90.48 | 23.85 |
Net Cash Growth | -17.98% | -44.17% | 106.04% | 279.42% | - |
Net Cash Per Share | 2.45 | 2.69 | 5.88 | 59.07 | 17.67 |
Filing Date Shares Outstanding | 40.88 | 36.88 | 35.64 | 28.27 | 1.75 |
Total Common Shares Outstanding | 39.67 | 35.88 | 35.62 | 1.72 | 1.75 |
Working Capital | 83.14 | 110.25 | 186.49 | 87.6 | 23.3 |
Book Value Per Share | 2.23 | 3.24 | 5.31 | -40.26 | -16.17 |
Tangible Book Value | 88.55 | 116.25 | 189.08 | -69.44 | -28.28 |
Tangible Book Value Per Share | 2.23 | 3.24 | 5.31 | -40.26 | -16.17 |
Machinery | - | 1.89 | 0.3 | 0.2 | - |
Construction In Progress | - | - | 0.94 | 0.1 | - |
Leasehold Improvements | - | 0.23 | - | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.